Alkem Laboratories Limited (BOM:539523)

India · Delayed Price · Currency is INR

5,497.80

+45.55 (0.84%)

At close: May 29, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	147.12B	129.65B	126.68B	115.99B	106.34B
Pharmaceuticals Growth	13.48%	2.34%	9.21%	9.08%	19.96%
Total	147.12B	129.65B	126.68B	115.99B	106.34B
Total Growth	13.48%	2.34%	9.21%	9.08%	19.96%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	98.51B	91.44B	86.62B	81.60B	75.27B
India Growth	7.74%	5.56%	6.15%	8.41%	29.30%
Other International	16.96B	13.39B	12.35B	9.26B	7.78B
Other International Growth	26.67%	8.47%	33.34%	18.94%	34.78%
United States (US)	29.85B	24.82B	27.71B	25.13B	23.29B
United States (US) Growth	20.26%	-10.44%	10.25%	7.91%	-5.57%
Total	145.32B	129.65B	126.68B	115.99B	106.34B
Total Growth	12.09%	2.34%	9.21%	9.08%	19.96%

Source: S&P Global Market Intelligence.